Polar Capital Holdings’s CG Oncology CGON Stock Holding History

Polar Capital Holdings’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.09M	Sell	43,483 -660,978	-94%	-$43.2M	0.01%	224
2026 Q1	$47.7M	Sell	704,461 -394,201	-36%	-$22.3M	0.17%	104
2025 Q4	$45.6M	Hold	1,098,662	–	–	0.18%	104
2025 Q3	$44.3M	Hold	1,098,662	–	–	0.21%	101
2025 Q2	$28.6M	Buy	1,098,662 +55,802	+5%	+$1.34M	0.15%	120
2025 Q1	$25.5M	Buy	1,042,860 +75,805	+8%	+$2.13M	0.16%	131
2024 Q4	$27.7M	Hold	967,055	–	–	0.16%	132
2024 Q3	$36.5M	Hold	967,055	–	–	0.17%	110
2024 Q2	$30.5M	Buy	967,055 +237,889	+33%	+$8.25M	0.18%	109
2024 Q1	$32M	Buy	+729,166	New	+$29.8M	0.17%	113

Other funds holding CGON

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Polar Capital Holdings's CGON Position: Q2 2026 in Review

Polar Capital Holdings reduced its CG Oncology (CGON) stake by 94% in Q2 2026, selling an estimated $43.2M and leaving 43,483 shares worth $3.09M. The position accounts for 0.01% of the portfolio, ranked #224.

Polar Capital Holdings first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. The position peaked at $47.7M in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

Polar Capital Holdings held 43,483 shares of CG Oncology worth $3.09M as of Q2 2026.
Polar Capital Holdings sold 660,978 CG Oncology shares in Q2 2026, an estimated $43.2M.
CG Oncology made up 0.01% of Polar Capital Holdings's portfolio in Q2 2026, its #224 holding.
Polar Capital Holdings first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
Polar Capital Holdings's CG Oncology position peaked at $47.7M in Q1 2026.
227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.